Literature DB >> 16396874

Neonatal effects of maternal hypothyroxinemia during early pregnancy.

Libbe Kooistra1, Susan Crawford, Anneloes L van Baar, Evelien P Brouwers, Victor J Pop.   

Abstract

OBJECTIVE: We sought to examine the neurobehavioral profile of neonates who are born to women with hypothyroxinemia during early pregnancy.
METHODS: Examined were 108 neonates who were born to mothers with low maternal free thyroid hormone (fT4 concentrations; <10th percentile) at 12 weeks' gestation (case patients) and 96 neonates who were born to women whose fT4 values were between the 50th and 90th percentiles, matched for parity and gravidity (control subjects). Newborn development was assessed at 3 weeks of age using the Neonatal Behavioral Assessment Scale. Maternal thyroid function (fT4 and thyrotropin hormone) was assessed at 12, 24, and 32 weeks' gestation.
RESULTS: Infants of women with hypothyroxinemia at 12 weeks' gestation had significantly lower scores on the Neonatal Behavioral Assessment Scale orientation index compared with subjects. Regression analysis showed that first-trimester maternal fT4 but not maternal TSH or fT4 later in gestation was a significant predictor of orientation scores.
CONCLUSIONS: This study confirms that maternal hypothyroxinemia constitutes a serious risk factor for neurodevelopmental difficulties that can be identified in neonates as young as 3 weeks of age.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16396874     DOI: 10.1542/peds.2005-0227

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  51 in total

Review 1.  Influence of maternal thyroid hormones during gestation on fetal brain development.

Authors:  N K Moog; S Entringer; C Heim; P D Wadhwa; N Kathmann; C Buss
Journal:  Neuroscience       Date:  2015-10-03       Impact factor: 3.590

2.  Gestational Hypothyroxinemia Affects Glutamatergic Synaptic Protein Distribution and Neuronal Plasticity Through Neuron-Astrocyte Interplay.

Authors:  Pablo Cisternas; Antoine Louveau; Susan M Bueno; Alexis M Kalergis; Hélène Boudin; Claudia A Riedel
Journal:  Mol Neurobiol       Date:  2015-12-19       Impact factor: 5.590

Review 3.  Maternal Hypothyroxinemia-Induced Neurodevelopmental Impairments in the Progeny.

Authors:  Hui Min; Jing Dong; Yi Wang; Yuan Wang; Weiping Teng; Qi Xi; Jie Chen
Journal:  Mol Neurobiol       Date:  2015-02-11       Impact factor: 5.590

4.  Antenatal thyroid screening and childhood cognitive function.

Authors:  John H Lazarus; Jonathan P Bestwick; Sue Channon; Ruth Paradice; Aldo Maina; Rhian Rees; Elisabetta Chiusano; Rhys John; Varvara Guaraldo; Lynne M George; Marco Perona; Daniela Dall'Amico; Arthur B Parkes; Mohammed Joomun; Nicholas J Wald
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

5.  Maternal isolated hypothyroxinemia: To treat or not to treat?

Authors:  M Moleti; F Vermiglio; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

6.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

7.  Re-thinking the definitions of subclinical thyroid disease in pregnancy.

Authors:  R Negro
Journal:  J Endocrinol Invest       Date:  2011-02-07       Impact factor: 4.256

Review 8.  Update on a new controversy in endocrinology: isolated maternal hypothyroxinemia.

Authors:  R M Furnica; J H Lazarus; D Gruson; C Daumerie
Journal:  J Endocrinol Invest       Date:  2014-11-05       Impact factor: 4.256

9.  Maternal hypothyroxinemia impairs spatial learning and synaptic nature and function in the offspring.

Authors:  M C Opazo; A Gianini; F Pancetti; G Azkcona; L Alarcón; R Lizana; V Noches; P A Gonzalez; M P Marassi; M Porto; S Mora; D Rosenthal; E Eugenin; D Naranjo; S M Bueno; A M Kalergis; C A Riedel
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

Review 10.  Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes.

Authors:  Mark D Miller; Kevin M Crofton; Deborah C Rice; R Thomas Zoeller
Journal:  Environ Health Perspect       Date:  2009-02-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.